Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodelingSusan M. Lin, Vera P. Krymskaya, Joseph D. Planer et al.|Journal of Clinical Investigation|2023Cited by 18
The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in LymphangioleiomyomatosisJilly F. Evans, Vera P. Krymskaya, O. Ledwell et al.|American Journal of Respiratory Cell and Molecular Biology|2024Cited by 7
Extracellular Matrix and Fibroblast Activation in LymphangioleiomyomatosisAlexander R. Mukhitov, Vera P. Krymskaya, Jilly F. Evans et al.|American Journal of Respiratory Cell and Molecular Biology|2025Cited by 1
Unique Transcriptomic and Proteomic Signature of mTORC1 Hyperactivation in Lung MesenchymeO. Ledwell, Vera P. Krymskaya, Ryan W. Rue et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0
Extracellular Matrix Proteins and Signaling in LymphangioleiomyomatosisAlexander R. Mukhitov, Vera P. Krymskaya, Jillian F. Evans et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0